Objetivo The basic principles underlying tumour immunology have evolved considerably. It has been established that :(1) the normal immune system is rarely a significant barrier to tumour growth, (2) most tumours are antigenic but few spontaneous tumours are immunogenic and (3) manipulation of the immune system can result in complete tumour eradication. Although the first two principles are well established, the third has been shown in only a few cases so far. In fact, immunotherapy often fails or is otherwise inadequate even in the presence of a potent immune response. It is therefore crucial to probe (1) which properties of the immune system contribute to poor immunogenicity and how the this property can be stimulated and (2) how cancer cells present tumour-related barriers to immunotherapy. Ámbito científico medical and health sciencesclinical medicineoncologymedical and health sciencesbasic medicineimmunologyimmunotherapy Programa(s) FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002 Tema(s) 1.1.1.-7. - Chronic and degenerative diseases, cancer, diabetes, cardivascular diseases and rare diseases Convocatoria de propuestas Data not available Régimen de financiación ACM - Preparatory, accompanying and support measures Coordinador SAINT SAVAS CANCER HOSPITAL Aportación de la UE Sin datos Dirección Alexandras Ave 171 11522 ATHENS Grecia Ver en el mapa Coste total Sin datos